In contrast, a variety of RAFi have consistently failed to progress through the clinic for tumours with wild type (WT) RAF, including those with RAS mutations, because they cause paradoxical activation of RAF and ERK1/2 signalling12,13. Here, MAPK3 is linked to neoplasm.